Under the terms of agreement, ContextVision will have the exclusive rights for a new 3D rendering technology within the field of ultrasound medical imaging.
As a first step, and in collaboration with Vistinct, ContextVision will develop a new ultrasound product that will help manufacturers deliver more realistic prenatal ultrasound images.
ContextVision CEO Anita Tollstadius said the Vistinct research team is excellent and the company has already established a very fruitful collaboration.
"By acquiring the rights to this advanced technology we will strengthen our position in 3D ultrasound," Tollstadius added.
"We believe that a product based on this rendering software will complement our 3D image enhancement portfolio in a very good way."
The company anticipates the first product to be commercially available by the end of 2014.
